What do disparate parts of the world such as Denmark, Sweden, Norway, Holland, Western Australia, and other Scandinavian countries have in common? From an infectious diseases perspective, they all have similarly low rates of healthcare-associated MRSA (and other antibiotic-resistant bacteria) despite being developed countries/regions with sophisticated healthcare. Denmark’s success in controlling healthcare-associated MRSA despite initial […]

There has been considerable variability in terms of MRSA control in hospitals around the world. This can perhaps be best shown if one looks at the antimicrobial resistance surveillance report published by the European CDC (latest = 2012). I have taken the liberty to copy the relevant diagram (below). It can be seen that the […]